Menthol oil (Solution) Instructions for Use
Marketing Authorization Holder
Tula Pharmaceutical Factory, LLC (Russia)
ATC Code
M02AX10 (Other drugs)
Active Substance
Levomenthol (Rec.INN registered by WHO)
Dosage Forms
| Menthol oil | Solution for topical application and inhalations 1%: 10 ml or 25 ml bottle or dropper bottle. | |
| Solution for topical application and inhalations 2%: 10 ml or 25 ml bottle or dropper bottle. |
Dosage Form, Packaging, and Composition
Solution for topical application and inhalations colorless, oily, with a faint odor of menthol.
| 100 g | |
| Levomenthol | 1 g |
Excipients : liquid paraffin 99 g.
10 ml – orange glass bottles (1) – cardboard packs.
25 ml – orange glass bottles (1) – cardboard packs.
10 ml – orange glass dropper bottles (1) – cardboard packs.
25 ml – orange glass dropper bottles (1) – cardboard packs.
Solution for topical application and inhalations colorless, oily, with a faint odor of menthol.
| 100 g | |
| Levomenthol | 2 g |
Excipients : liquid paraffin 98 g.
10 ml – orange glass bottles (1) – cardboard packs.
25 ml – orange glass bottles (1) – cardboard packs.
10 ml – orange glass dropper bottles (1) – cardboard packs.
25 ml – orange glass dropper bottles (1) – cardboard packs.
Clinical-Pharmacological Group
A drug with counterirritant action for topical use in ENT practice
Pharmacotherapeutic Group
Other drugs for the treatment of respiratory system diseases
Pharmacological Action
A counterirritant agent; when applied to the skin, it exerts some antimicrobial and anti-inflammatory action, accompanied by a reduction in the severity of pain and itching.
The irritant (distracting) effect helps to eliminate pain sensations.
The local action is accompanied by vasoconstriction, a sensation of cold, turning into a sensation of slight burning and tingling.
Cutaneovisceral effects (the reflex arc does not involve the brain) improve tissue trophism (according to the zones of innervation).
Indications
- Infectious and inflammatory diseases of the upper respiratory tract (rhinitis, pharyngitis, laryngitis, tracheitis).
ICD codes
| ICD-10 code | Indication |
| J00 | Acute nasopharyngitis (common cold) |
| J02 | Acute pharyngitis |
| J04 | Acute laryngitis and tracheitis |
| J31 | Chronic rhinitis, nasopharyngitis and pharyngitis |
| J37 | Chronic laryngitis and laryngotracheitis |
| ICD-11 code | Indication |
| CA00 | Acute nasopharyngitis |
| CA02.Z | Acute pharyngitis, unspecified |
| CA05 | Acute laryngitis or tracheitis |
| CA09 | Chronic rhinitis, nasopharyngitis or pharyngitis |
| CA0G | Chronic laryngitis or laryngotracheitis |
Dosage Regimen
| The method of application and dosage regimen for a specific drug depend on its form of release and other factors. The optimal dosage regimen is determined by the doctor. It is necessary to strictly adhere to the compliance of the dosage form of a specific drug with the indications for use and dosage regimen. |
Apply topically only. Avoid contact with eyes and mucous membranes.
For steam inhalations in respiratory tract diseases, use 15-20 drops per 200 ml of hot water. Inhale the vapors for 5-10 minutes, 2-3 times daily.
For intranasal application in rhinitis, apply 5-10 drops into each nasal passage. Use 2-3 times a day.
For topical application on skin, apply a small amount to the affected area and rub in gently. Use 2-3 times daily.
Do not apply to damaged skin or open wounds. The maximum duration of continuous use is 5-7 days.
Discontinue use if skin irritation or allergic reactions occur. Do not use in children under 3 years of age due to risk of reflex respiratory depression.
Adverse Reactions
Allergic reactions, contact dermatitis; with intranasal application in children – reflex respiratory depression (up to apnea) and collapse.
Contraindications
- Children under 3 years of age;
- Bronchial asthma;
- Individual hypersensitivity to the drug components.
Use in Pregnancy and Lactation
The use of the drug during pregnancy and breastfeeding is contraindicated (due to insufficient clinical data).
Pediatric Use
Contraindicated in children under 3 years of age.
Special Precautions
Effect on the ability to drive vehicles and machinery
The use of the drug does not affect the performance of potentially hazardous activities requiring increased attention and rapid reactions (driving vehicles, working with moving mechanisms).
Overdose
Overdose may lead to an increase in side effects.
Treatment symptomatic.
Drug Interactions
Not described.
Storage Conditions
In a place protected from light at a temperature not exceeding 15°C (59°F). Keep out of reach of children.
Shelf Life
Shelf life – 4 years.
Dispensing Status
Over-the-counter.
Important Safety Information
This information is for educational purposes only and does not replace professional medical advice. Always consult your doctor before use. Dosage and side effects may vary. Use only as prescribed.
Medical Disclaimer
Kagocel pills 12mg, 30pcs
Cortexin, 10mg, 5ml, 10pcs
Actovegin pills 200mg, 50pcs
Nootropil pills 800mg, 30pcs
Ingavirin capsules 90mg, 10pcs
Noopept, pills 10mg, 50pcs
No-spa pills 40mg, 64pcs
Belosalic, ointment, 30g
Belosalic, lotion solution for external use spray 100ml
Cerebrolysin, solution for injection 2ml ampoules 10pcs
Phenibut-Vertex pills 250mg, 20pcs
Mildronate capsules 500mg, 90pcs
Fenotropil pills 100mg, 60pcs
Arbidol, capsules 100mg, 40pcs
Daivobet, ointment, 30g
OKI, sachets 80mg 2g, 12pcs
Picamilon pills 50mg, 60pcs 